METASTATIC GI CANCERS

Clinical trials for METASTATIC GI CANCERS explained in plain language.

Never miss a new study

Get alerted when new METASTATIC GI CANCERS trials appear

Sign up with your email to follow new studies for METASTATIC GI CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for patients with aggressive cancers that have run out of options

Disease control Ongoing

This study is testing the safety and effectiveness of a new two-drug combination for people with advanced colorectal and other gastrointestinal cancers that have stopped responding to standard treatments. The trial combines an oral pill (vorbipiprant) with an immunotherapy drug (…

Matched conditions: METASTATIC GI CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Rottapharm Biotech • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

METASTATIC GI CANCERS

Get alerted when new METASTATIC GI CANCERS trials appear

New hope for patients with aggressive cancers that have run out of options